Life sciences
What does Merck’s pulled £1bn plan actually mean for UK life sciences?
The big pharma firm’s decision is about more than real estate as negotiations with the government hang in the balance
High-profile activist turns attention to listed UK real estate
Saba has built stakes in Workspace and Life Science REIT
Merck scraps £1bn London research hub plans
US drugmaker intends to move its research back to existing sites in the States
Latest Articles
Life sciences is making a comeback – investors should watch closely
The return of urban hubs and a buoyant M&A market are creating fresh opportunities
Colonial and Stoneshield close €30m debut deal for science platform
Partners have ambitions to scale to €2.4bn under management
CBRE inks partnership with Grow London
Role as strategic adviser to support investment opportunities in the capital's real estate market
Consent granted for Cambridge life sciences scheme
Paddocks Business Centre will become a med-tech research and development facility
Life Science REIT sale receiving “significant interest”
Firm confirms interest from a range of buyers, in its latest trading update
L&G refinances Amsterdam life sciences property with €38m loan
Loan is part of its UK and Europe lending strategy